Voyager Therapeutics (VYGR) EBT Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,297.00 |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | -115,976.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115,976.00 |
| Dec 31, 2025 | -170,156.00 |
| Sep 30, 2025 | -25,043.00 |
| Jun 30, 2025 | 203,909.00 |
| Mar 31, 2025 | 276,329.00 |
| Dec 31, 2024 | -55,608.00 |
| Sep 30, 2024 | 165,205.00 |
| Jun 30, 2024 | 206,877.00 |
| Mar 31, 2024 | 33,529.00 |
| Dec 31, 2023 | 42,525.00 |
| Sep 30, 2023 | -63,886.00 |
| Jun 30, 2023 | -42,191.00 |
| Mar 31, 2023 | 21,272.00 |
| Dec 31, 2022 | 156,171.00 |
| Sep 30, 2022 | 11,634.00 |
| Jun 30, 2022 | -270,496.00 |
| Mar 31, 2022 | -271,717.00 |
| Dec 31, 2021 | 114,008.00 |
| Sep 30, 2021 | -71,969.00 |
| Jun 30, 2021 | -111,106.00 |
| Mar 31, 2021 | 174,107.00 |
| Dec 31, 2020 | -17,584.00 |
| Sep 30, 2020 | 210,557.00 |
| Jun 30, 2020 | 155,706.00 |
| Mar 31, 2020 | 102,277.00 |
| Dec 31, 2019 | 56,770.00 |
| Sep 30, 2019 | 20,767.00 |
| Jun 30, 2019 | 27,514.00 |
| Mar 31, 2019 | -37,398.00 |
| Dec 31, 2018 | -97,454.00 |
| Sep 30, 2018 | -88,957.00 |
| Jun 30, 2018 | -91,363.00 |
| Mar 31, 2018 | -156,852.00 |